Home » Topics » BioWorld Science

BioWorld Science
RSS

IL-1alpha inhibition reduces hyperinflammation in a COVID-19 murine model

July 16, 2021

Novel PIV5-based mucosal vaccine protects mice and ferrets against SARS-CoV-2 challenge

July 16, 2021

Tumor suppressor p53 is inactivated by lncRNA

July 16, 2021

First patient dosed in global phase I study of TST-005

July 16, 2021

Serum HBD2 is a marker of chronic spontaneous urticaria

July 16, 2021

Positive topline data from phase Ib study of GLPG-3667 in psoriasis

July 16, 2021

GLPG-3970 shows clinical activity in early phase clinical trials

July 16, 2021

Blue Water Vaccines licenses novel VLP vaccine platform from Cincinnati Children's

July 16, 2021

FDA accepts IND application for phase I/II study of ExoFlo in ARDS

July 16, 2021

Serum miR-146a is elevated in patients with COVID-19

July 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...